Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect Of Fractional CO2 Laser Therapy On Cancer Survivors With Genitourinary Syndrome Of Menopause (GSM)

NCT06318052 is registered in ClinicalTrials.gov with Lumenis Be Ltd. as lead sponsor.

NCT NCT06318052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06318052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect Of Fractional CO2 Laser Therapy On Cancer Survivors With Genitourinary Syndrome Of Menopause (GSM)
Lead sponsor
Lumenis Be Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
November 1, 2019
Completion date
November 30, 2024
Enrollment
68 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vaginal atrophy patients with gsm